aDepartment of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei

bDepartment of Internal Medicine, National Taiwan University Hospital Yun-Lin Branch, Yun-Lin

cGraduate Institute of Clinical Medicine, College of Medicine, National Taiwan University

dDepartment of Medicine, National Taiwan University Cancer Center, Taipei

eDepartment of Cardiovascular Medicine, Far Eastern Memorial Hospital, New Taipei City

fGraduate Institute of Medicine, Yuan Ze University, Taoyuan City

gDepartment of Medical Imaging, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei

hDepartment of Computer Science and Engineering, Yuan Ze University, Taoyuan City

iDivision of Cardiology, Department of Internal Medicine, Taipei Veterans General Hospital

jDepartment of Nuclear Medicine, National Taiwan University Hospital

kDepartment of Urology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan

Correspondence to Yen-Hung Lin, MD, PhD, Department of Internal Medicine, National Taiwan University Hospital, No. 7, Chung-Shan South Road, Taipei 100, Taiwan. Tel: +886 2 23123456 x62152; fax: + 886 2 23515811; e-mail: [email protected] or [email protected]

Abbreviations: ACEI, angiotensin-converting enzyme inhibitor; APA, aldosterone-producing adenoma; ARB, angiotensin receptor blocker; ARR, aldosterone–renin ratio; CCB, calcium channel blocker; MBP, mean blood pressure; MRAs, mineralocorticoid receptor antagonists; PAC, plasma aldosterone concentration; PRA, plasma renin activity; PSM, propensity score matching; PWV, pulse wave velocity

Received 3 January, 2023

Revised 7 October, 2023

Accepted 16 November, 2023

Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Website (http://www.jhypertension.com).